Topics
Cystoid Macular Edema
Diabetic Retinopathy
Genetics and Nutrition in Retinal Disease
Emerging Data to Guide Clinical Decisions: Treating the AMD Patient
This continuing medical education activity is supported by an unrestricted educational grant from Genentech Inc.
View Supplement
Next-Generation OCT Technology
A Multi-Disciplinary Approach to the Management of Cystoid MacularEdema
This continuing medical education activity is supported by an unrestricted educational grant from Allergan, Inc.
Vitreoretinal Surgery
Clinical Cases: NSAIDs for CME
This continuing medical education activity is supported by an unrestricted educational grant from Alcon Laboratories.
View Insert
FIELD Study Revealed Fenofibrate Reduced Need for Laser Treatment for Diabetic Retinopathy
This continuing medical education activity is supported by an unrestricted educational grant from Abbott Laboratories.
Combination Therapy for AMD
Implementing New Data to Treat the AMD Patient
This continuing medical education activity is supported by an unrestricted educational grant from Genentech.
Free Print Subscription
Email Newsletter
Conference Calendar
November 17, 2026
MacuMira Receives CE Mark Certification for Retinal Microcurrent Stimulation Device to Treat Dry AMD
November 16, 2026
Johnson & Johnson to Acquire Ollin Biosciences for $2.2 Billion, Advancing Retinal Disease Pipeline
RetinaLyze System Receives EU MDR Class 2a Certification for Retinal Screening Software
November 11, 2026
AAO, AOA Respond to FDA GLP-1 Drug Labeling Changes, Highlight NAION Risk and Eye Care Recommendations